Abstract
Objectives. In patients with extracranial neoplasms, the occurrence and number of brain metastases (BM) are critical for further diagnostic approaches and therapeutic strategies and the patient's prognosis. Although widely accepted, there is surprisingly little evidence in the literature that MRI is superior to CCT. Therefore, in patients with solitary BM according to diagnostic contrast-enhanced computed tomography (CCT), we investigated, what additional information could be gained by contrast-enhanced magnetic resonance imaging (MRI).
Methods/Results. Among 55 patients with solitary BM according to CCT, 17 had multiple BM on MRI (31%) and 38 had solitary BM in both. Based on a presumed binomial distribution of our data, we calculated a rate of at least 19% of patients with solitary BM on CCT, in which MRI would show multiple lesions (p=0.05). The two main characteristics for BM missed by CCT were the smaller diameter, which averages 2 cm less than in BM identified with both modalities, and a preferential frontotemporal location.
Conclusion. MRI is indeed superior to CCT in the diagnosis of BM the essential reasons besides detection of smaller lesions being a better soft tissue contrast, significantly stronger enhancement with paramagnetic contrast agents, the lack of bone artifacts, fewer partial volume effects, and direct imaging in three different planes. Therefore, MRI is indispensable in the diagnostic workup of patients with BM for choosing the optimum therapeutic approach, especially with regard to the decision whether to operate or to primarily irradiate the patient's metastases.
Similar content being viewed by others
References
Patchell RA: Brain metastases. Neurol Clin 9(4): 817–824, 1991
Zimm S, Wampler GL, Stablein D, Hazra T, Young HF: Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48(2): 384–394, 1981
Chason JL, Walker FB, Landers JW: Metastatic carcinoma in the central nervous system and dorsal root ganglia – a prospective autopsy study. Cancer 16(June): 781–787, 1963
Pladdet I, Boven E, Nauta J, Pinedo HM: Palliative care for brain metastases of solid tumour types. Neth J Med 34(1–2): 10–21, 1989
Delattre JY, Krol G, Thaler HT, Posner JB: Distribution of brain metastases. Arch Neurol 45(7): 741–744, 1988
Russel DJ, Rubinstein LS: Secondary tumors of the nervous system. In: Pathology of Tumors of the Nervous System. Williams & Wilkins, Baltimore, 1989, pp 825–841
Batson OV: The role of the vertebral veins in metastatic processes. Annals of Internal Medicine 16: 38–45, 1942
Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 19: 579–592, 1978
McIntosh R, Thatcher N: Management of the solitary metastasis. Thorax 45(12): 909–911, 1990
Vecht CJ, Haaxma Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR et al.: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33(6): 583–590, 1993
Mandell L, Hilaris B, Sullivan M, Sundaresan N, Nori D, Kim JH, Martini N, Fuks Z: The treatment of single brain metastasis from non-oat cell lung carcinoma. Surgery and radiation versus radiation therapy alone. Cancer 58(3): 641–649, 1986
DeAngelis LM, Mandell LR, Thaler HT, Kimmel DW, Galicich JH, Fuks Z, Posner JB: The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 24(6): 798–805, 1989
Black PM: Solitary brain metastases. Radiation, resection, or radiosurgery? Chest 103(4 Suppl): 367s–369s, 1993
Sawaya R: Neurosurgery issues in oncology. Curr Opin Oncol 3(3): 459–466, 1991
Fallai C, Olmi P: Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors, and brain metastases). Radiother Oncol 43(3): 235–246, 1997
Wowra B, Horstmann GA, Cibis R, Czempiel H: Profile of ambulatory radiosurgery with the gamma knife system. 2: Report of clinical experiences. Radiology 37(12): 1003–1015, 1997
Schoggl A, Kitz K, Ertl A, Dieckmann K, Saringer W, Koos WT: Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients. Acta Neurochir Wien 140(6): 549–555, 1998
Patchell RA, Cirrincione C, ThalerHT, Galicich JH, KimJH, Posner JB: Single brain metastases: surgery plus radiation or radiation alone. Neurology 36(4): 447–453, 1986
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8): 494–500, 1990
Smalley SR, Laws ER, Jr JR OF, Shaw EG, Schray MF: Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients. J Neurosurg 77(4): 531–540, 1992
Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr: Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. AJNR 12(2): 293–300, 1991
Nemzek W, Poirier V, Salamat MS, Yu T: Carcinomatous encephalitis (miliary metastases): lack of contrast enhancement. AJNR 14(3): 540–542, 1993
Sze G, Milano E, Johnson C, Heier L: Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR 11(4): 785–791, 1990
Sze G, Shin J, Krol G, Johnson C, Liu D, Deck MD: Intraparenchymal brain metastases:MRimaging versus contrastenhanced CT. Radiology 168(1): 187–194, 1988
Terrier F, Schuknecht B, Fretz C, Vock P, Herschkowitz N: Magnetic resonance in oncology. Schweiz MedWochenschr 120(35): 1257–1272, 1990
Iaconetta G, Lamaida E, Rossi A, Signorelli F, Manto A, Giamundo A: Leptomeningeal carcinomatosis: reviewof the literature. Acta Neurol Napoli 16(4): 214–220, 1994
Watanabe M, Tanaka R, Takeda N: Correlation of MRI and clinical features in meningeal carcinomatosis. Neuroradiology 35(7): 512–515, 1993
Healy ME, Hesselink JR, Press GA, Middleton MS: Increased detection of intracranial metastases with intravenous Gd-DTPA. Radiology 165(3): 619–624, 1987
Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ: MRI evaluation of 'solitary' brain metastases with triple-dose gadoteridol: comparison with contrastenhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients. Comput Med Imaging Graph 18(5): 391–399, 1994
Russell EJ, Geremia GK, Johnson CE, Huckman MS, Ramsey RG, Washburn Bleck J, Turner DA, Norusis M: Multiple cerebral metastases: detectability with Gd-DTPAenhanced MR imaging. Radiology 165(3): 609–617, 1987
Akeson P, Larsson EM, Kristoffersen DT, Jonsson E, Holtas S: Brain metastases – comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhancedMR imaging. Acta Radiol 36(3): 300–306, 1995
Golfieri R, Cherryman GR, Olliff JF, Husband JE: Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis. Radiol Med Torino 82(1–2): 27–34, 1991
YuhWT, Engelken JD, Muhonen MG, Mayr NA, Fisher DJ, Ehrhardt JC: Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. AJNR 13(1): 335–345, 1992
Hazuka MB, Burleson WD, Stroud DN, Leonard CE, Lillehei KO, Kinzie JJ: Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy. J Clin Oncol 11(2): 369–373, 1993
Salvati M, Cervoni L, Raco A: Single brain metastases from unknown primary malignancies in CT-era. J Neuro-Oncol 23(1): 75–80, 1995
White KT, Fleming TR, Laws ER Jr: Single metastasis to the brain. Surgical treatment in 122 consecutive patients. Mayo Clin Proc 56(7): 424–428, 1981
Forsting M, ReithW, Hartmann M, Knauth M: Hochdosierte Gabe von paramagnetischen Kontrastmitteln in der Diagnostik fokaler Hirnlôsionen. Radiology (36): 101–106, 1996
Knauth M, Forsting M, Hartmann M, Heiland S, Balzer T, Sartor K: MR Enhancement of brain lesions: increased contrast dose compared with magnetization transfer. AJNR 17(10): 1853–1859, 1996
Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Mori K, TominagaK: Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 115(3): 714–719, 1999
PerettiViton P, Margain D, Murayama N, Kadr I, Peragut JC: Brain metastases. J Neuroradiol 18(2): 161–172, 1991
Higer HP, Pedrosa P, Schuth M: MR imaging of cerebral tumors: state of the art and work in progress. Neurosurg Rev 12(2): 91–106, 1989
Claussen C, Laniado M, Kazner E, Schorner W, Felix R: Application of contrast agents in CT and MRI (NMR): their potential in imaging of brain tumors. Neuroradiology 27(2): 164–171, 1985
Claussen C, Laniado M, Schorner W, Niendorf HP, Weinmann HJ, Fiegler W, Felix R: Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases. AJNR 6(5): 669–674, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schellinger, P.D., Meinck, H.M. & Thron, A. Diagnostic Accuracy of MRI Compared to CCT in Patients with Brain Metastases. J Neurooncol 44, 275–281 (1999). https://doi.org/10.1023/A:1006308808769
Issue Date:
DOI: https://doi.org/10.1023/A:1006308808769